» Articles » PMID: 36292045

Long-Term Psychosocial Consequences of Whole-Body Magnetic Resonance Imaging and Reporting of Incidental Findings in a Population-Based Cohort Study

Overview
Specialty Radiology
Date 2022 Oct 27
PMID 36292045
Authors
Affiliations
Soon will be listed here.
Abstract

Management of radiological incidental findings (IF) is of rising importance; however, psychosocial implications of IF reporting remain unclear. We compared long-term psychosocial effects between individuals who underwent whole-body magnetic resonance imaging (MRI) with and without reported IF, and individuals who did not undergo imaging. We used a longitudinal population-based cohort from Western Europe. Longitudinal analysis included three examinations (exam 1, 6 years prior to MRI; exam 2, MRI; exam 3, 4 years after MRI). Psychosocial outcomes included PHQ-9 (Patient Health Questionnaire), DEEX (Depression and Exhaustion Scale), PSS-10 (Perceived Stress Scale) and a Somatization Scale. Univariate analyses and adjusted linear mixed models were calculated. Among 855 included individuals, 25% (n = 212) underwent MRI and 6% (n = 50) had at least one reported IF. Compared to MRI participants, non-participants had a higher psychosocial burden indicated by PHQ-9 in exam 1 (3.3 ± 3.3 vs. 2.5 ± 2.3) and DEEX (8.6 ± 4.7 vs. 7.7 ± 4.4), Somatization Scale (5.9 ± 4.3 vs. 4.8 ± 3.8) and PSS-10 (14.7 ± 5.7 vs. 13.7 ± 5.3, all p < 0.05) in exam 3. MRI participation without IF reporting was significantly associated with lower values of DEEX, PHQ-9 and Somatization Scale. There were no significant differences at the three timepoints between MRI participants with and without IF. In conclusion, individuals who voluntarily participated in whole-body MRI had less psychosocial burden and imaging and IF reporting were not associated with adverse long-term psychosocial consequences. However, due to the study design we cannot conclude that the MRI exam itself represented a beneficial intervention causing improvement in mental health scores.

References
1.
Levis B, Benedetti A, Thombs B . Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019; 365:l1476. PMC: 6454318. DOI: 10.1136/bmj.l1476. View

2.
Giannelis A, Palmos A, Hagenaars S, Breen G, Lewis C, Mutz J . Examining the association between family status and depression in the UK Biobank. J Affect Disord. 2020; 279:585-598. PMC: 7780845. DOI: 10.1016/j.jad.2020.10.017. View

3.
Hommes D, Klatte D, Otten W, Beltman M, Klass G, Zand A . Health outcomes and experiences of direct-to-consumer high-intensity screening using both whole-body magnetic resonance imaging and cardiological examination. PLoS One. 2020; 15(11):e0242066. PMC: 7678982. DOI: 10.1371/journal.pone.0242066. View

4.
Zugni F, Padhani A, Koh D, Summers P, Bellomi M, Petralia G . Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations. Cancer Imaging. 2020; 20(1):34. PMC: 7216394. DOI: 10.1186/s40644-020-00315-0. View

5.
Hildrum B, Mykletun A, Stordal E, Bjelland I, Dahl A, Holmen J . Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study. J Epidemiol Community Health. 2006; 61(1):53-8. PMC: 2465598. DOI: 10.1136/jech.2005.044966. View